Each year, Mayo Clinic cochlear implant teams implant more than 150 cochlear implant systems in adults and children. Mayo Clinic has performed cochlear implants in children as young as 4 months of age and in adults up to age 96.
Mayo Clinic's Cochlear Implant Facility in Rochester, Minnesota, was one of the first programs to use cochlear implants to treat children with auditory neuropathy spectrum disorder (ANSD). Mayo Clinic's cochlear implant team has successfully treated a large number of children with ANSD who did not benefit from hearing aids.
Recent improvements in cochlear-implant technology mean that a broad group of adults and children with hearing impairment can now benefit from the use of an implant system. Mayo Clinic offers the latest technology available for cochlear implants, including hybrid cochlear implants.
Hybrid cochlear implants stimulate the area at the base of the cochlea electrically, while also providing the acoustic amplification of a hearing aid. Hybrid devices preserve residual hearing in an ear by using both cochlear implant technology and a traditional hearing aid apparatus in the same ear.
Mayo Clinic has a long history of participation in research involving innovations of hardware and software used in cochlear implantation and programming. Specific efforts include studies of cochlear implants for unilateral hearing loss in adults and children, improved electrodes, and the use of cochlear implants in people with inner-ear schwannomas.
Other areas of research focus on children, including efforts to determine the effectiveness of cochlear implants for children with less severe hearing loss.
Nationally recognized expertise
Mayo Clinic in Rochester, Minn., Mayo Clinic in Scottsdale, Ariz., and Mayo Clinic in Jacksonville, Fla., are ranked among the Best Hospitals for ear, nose and throat by U.S. News & World Report.